Bulandres, Jameson A.

HRN: 07-99-64  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/09/2023
CEFUROXIME 1.5GM (VIAL)
11/09/2023
11/16/2023
IV
1.5g
Q8h
Abrasions, Laceration
Checking Final Appropriateness 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: